Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease Ia

Glycogen storage disease type Ia (GSD Ia) is the inherited deficiency of glucose-6-phosphatase (G6Pase), associated with life-threatening hypoglycemia and long-term complications, including hepatocellular carcinoma formation. Gene replacement therapy fails to stably reverse G6Pase deficiency. We att...

Full description

Bibliographic Details
Main Authors: Benjamin Arnson, Hye Ri Kang, Elizabeth D. Brooks, Dorothy Gheorghiu, Ekaterina Ilich, David Courtney, Jeffrey I. Everitt, Bryan R. Cullen, Dwight D. Koeberl
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050123000372
_version_ 1797807184255385600
author Benjamin Arnson
Hye Ri Kang
Elizabeth D. Brooks
Dorothy Gheorghiu
Ekaterina Ilich
David Courtney
Jeffrey I. Everitt
Bryan R. Cullen
Dwight D. Koeberl
author_facet Benjamin Arnson
Hye Ri Kang
Elizabeth D. Brooks
Dorothy Gheorghiu
Ekaterina Ilich
David Courtney
Jeffrey I. Everitt
Bryan R. Cullen
Dwight D. Koeberl
author_sort Benjamin Arnson
collection DOAJ
description Glycogen storage disease type Ia (GSD Ia) is the inherited deficiency of glucose-6-phosphatase (G6Pase), associated with life-threatening hypoglycemia and long-term complications, including hepatocellular carcinoma formation. Gene replacement therapy fails to stably reverse G6Pase deficiency. We attempted genome editing using two adeno-associated virus vectors, one that expressed Staphylococcus aureus Cas9 protein and a second containing a donor transgene encoding G6Pase, in a dog model for GSD Ia. We demonstrated donor transgene integration in the liver of three adult-treated dogs accompanied by stable G6Pase expression and correction of hypoglycemia during fasting. Two puppies with GSD Ia were treated by genome editing that achieved donor transgene integration in the liver. Integration frequency ranged from 0.5% to 1% for all dogs. In adult-treated dogs, anti-SaCas9 antibodies were detected before genome editing, reflecting prior exposure to S. aureus. Nuclease activity was low, as reflected by a low percentage of indel formation at the predicted site of SaCas9 cutting that indicated double-stranded breaks followed by non-homologous end-joining. Thus, genome editing can integrate a therapeutic transgene in the liver of a large animal model, either early or later in life, and further development is warranted to provide a more stable treatment for GSD Ia.
first_indexed 2024-03-13T06:18:45Z
format Article
id doaj.art-8282e120c0924cec897cf976a2665255
institution Directory Open Access Journal
issn 2329-0501
language English
last_indexed 2024-03-13T06:18:45Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Molecular Therapy: Methods & Clinical Development
spelling doaj.art-8282e120c0924cec897cf976a26652552023-06-10T04:27:42ZengElsevierMolecular Therapy: Methods & Clinical Development2329-05012023-06-0129108119Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease IaBenjamin Arnson0Hye Ri Kang1Elizabeth D. Brooks2Dorothy Gheorghiu3Ekaterina Ilich4David Courtney5Jeffrey I. Everitt6Bryan R. Cullen7Dwight D. Koeberl8Division of Medical Genetics, Department of Pediatrics, Duke University Medical School, Durham, NC, USA; Department of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, NC, USADepartment of Pediatrics, UT Southwestern Medical Center, Dallas, TX, USADivision of Medical Genetics, Department of Pediatrics, Duke University Medical School, Durham, NC, USADivision of Medical Genetics, Department of Pediatrics, Duke University Medical School, Durham, NC, USADivision of Medical Genetics, Department of Pediatrics, Duke University Medical School, Durham, NC, USAWellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, UKDepartment of Pathology, Duke University School of Medicine, Durham, NC, USADepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, NC, USADivision of Medical Genetics, Department of Pediatrics, Duke University Medical School, Durham, NC, USA; Department of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, NC, USA; Corresponding author: Dwight D. Koeberl, Box 103856, Duke University Medical Center, Durham, NC 27710, USA.Glycogen storage disease type Ia (GSD Ia) is the inherited deficiency of glucose-6-phosphatase (G6Pase), associated with life-threatening hypoglycemia and long-term complications, including hepatocellular carcinoma formation. Gene replacement therapy fails to stably reverse G6Pase deficiency. We attempted genome editing using two adeno-associated virus vectors, one that expressed Staphylococcus aureus Cas9 protein and a second containing a donor transgene encoding G6Pase, in a dog model for GSD Ia. We demonstrated donor transgene integration in the liver of three adult-treated dogs accompanied by stable G6Pase expression and correction of hypoglycemia during fasting. Two puppies with GSD Ia were treated by genome editing that achieved donor transgene integration in the liver. Integration frequency ranged from 0.5% to 1% for all dogs. In adult-treated dogs, anti-SaCas9 antibodies were detected before genome editing, reflecting prior exposure to S. aureus. Nuclease activity was low, as reflected by a low percentage of indel formation at the predicted site of SaCas9 cutting that indicated double-stranded breaks followed by non-homologous end-joining. Thus, genome editing can integrate a therapeutic transgene in the liver of a large animal model, either early or later in life, and further development is warranted to provide a more stable treatment for GSD Ia.http://www.sciencedirect.com/science/article/pii/S2329050123000372genome editingCRISPR-Cas9adeno-associated virus vectorsinherited disorder of metabolismglycogen storage diseaseglucose-6-phosphatase
spellingShingle Benjamin Arnson
Hye Ri Kang
Elizabeth D. Brooks
Dorothy Gheorghiu
Ekaterina Ilich
David Courtney
Jeffrey I. Everitt
Bryan R. Cullen
Dwight D. Koeberl
Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease Ia
Molecular Therapy: Methods & Clinical Development
genome editing
CRISPR-Cas9
adeno-associated virus vectors
inherited disorder of metabolism
glycogen storage disease
glucose-6-phosphatase
title Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease Ia
title_full Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease Ia
title_fullStr Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease Ia
title_full_unstemmed Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease Ia
title_short Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease Ia
title_sort genome editing using staphylococcus aureus cas9 in a canine model of glycogen storage disease ia
topic genome editing
CRISPR-Cas9
adeno-associated virus vectors
inherited disorder of metabolism
glycogen storage disease
glucose-6-phosphatase
url http://www.sciencedirect.com/science/article/pii/S2329050123000372
work_keys_str_mv AT benjaminarnson genomeeditingusingstaphylococcusaureuscas9inacaninemodelofglycogenstoragediseaseia
AT hyerikang genomeeditingusingstaphylococcusaureuscas9inacaninemodelofglycogenstoragediseaseia
AT elizabethdbrooks genomeeditingusingstaphylococcusaureuscas9inacaninemodelofglycogenstoragediseaseia
AT dorothygheorghiu genomeeditingusingstaphylococcusaureuscas9inacaninemodelofglycogenstoragediseaseia
AT ekaterinailich genomeeditingusingstaphylococcusaureuscas9inacaninemodelofglycogenstoragediseaseia
AT davidcourtney genomeeditingusingstaphylococcusaureuscas9inacaninemodelofglycogenstoragediseaseia
AT jeffreyieveritt genomeeditingusingstaphylococcusaureuscas9inacaninemodelofglycogenstoragediseaseia
AT bryanrcullen genomeeditingusingstaphylococcusaureuscas9inacaninemodelofglycogenstoragediseaseia
AT dwightdkoeberl genomeeditingusingstaphylococcusaureuscas9inacaninemodelofglycogenstoragediseaseia